Cognitive Disorders Amnestic Dementia Delirium (Clerambault Syndrome)

Subscribe to Selected New Research on Cognitive Disorders Amnestic Dementia Delirium

45 relevant articles (2 outcomes, 5 trials/studies) found for this Disease

Description: Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.

Also Known As:

Clerambault Syndrome; Delirium, Dementia, Amnestic, Cognitive Disorders; Nonpsychotic Organic Brain Syndrome; Disorders, Organic Mental; Mental Disorder, Organic; Organic Mental Disorder; Traumatic Psychoses; Kandinsky Syndrome; Mental Disorders, Organic; Organic Brain Syndrome, Nonpsychotic; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Psychoses, Traumatic

Relationship Network

Disease Context: Research Results

Mental Disorders: 1709

Cognitive Disorders Amnestic Dementia Delirium: 45

Dementia: 10685

Amnesia: 1854

Delirium: 1603

Consciousness Disorders: 85

Cognition Disorders: 12

Acquired Dyslexia

Related Diseases

1.	Psychotic Disorders (Schizoaffective Disorder)
2.	Anxiety Disorders (Anxiety Disorder)
3.	Mood Disorders (Mood Disorder)
4.	Schizophrenia (Dementia Praecox)
5.	Sleep Initiation and Maintenance Disorders (Insomnia)

Experts

1.	Alcántara Lapaz, Antonio G: 1 article (12/2002)
2.	García-Fernández, Lorena: 1 article (12/2002)
3.	Martinez Herrera, Ma José: 1 article (12/2002)
4.	Reznik, A M: 1 article (05/2002)
5.	Arbuzov, A L: 1 article (05/2002)
6.	Litvintsev, S V: 1 article (05/2002)
7.	Shamreĭ, V K: 1 article (05/2002)
8.	Armenta, W: 1 article (02/2000)
9.	Alao, A O: 1 article (02/2000)
10.	Yolles, J C: 1 article (02/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cognitive Disorders Amnestic Dementia Delirium:

1.	Piracetam (Nootropil)IBA 07/01/1986 - "The following paper presents an investigation of the efficacy of piracetam in alcoholic organic mental disorder" 01/01/1990 - "High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study." 07/01/1986 - "Piracetam in alcoholic organic mental disorder: a placebo controlled study comparing two dosages." 01/01/1990 - "6 g and 24 g per die) was performed to evaluate the benefits of high dose piracetam in the treatment of organic mental disorder of chronic alcohol addicts" 01/01/1990 - "A marked tendency to increase the dose of piracetam in the treatment of organic mental disorder can be observed in clinical practice" Order ALL the reference details at left...
2.	Antipsychotic Agents (Antipsychotics)IBA 01/01/1993 - "Antipsychotic agents are useful in the treatment of psychosis due to both functional disorders (i.e., idiopathic disorders that are usually treated by psychiatrists) and organic mental disorders" Order ALL the reference details at left...
3.	Selegiline (E250)FDA LinkGeneric 01/01/1991 - "119 patients were enrolled in a double-blind randomized parallel study versus placebo carried out to assess both the efficacy and tolerability of L-deprenyl (10 mg/day) for treatment of patients with organic mental disorders of the Alzheimer type (DAT)" Order ALL the reference details at left...
4.	Methamphetamine (Desoxyn)FDA Link 10/01/1990 - "This study examines the clinical characteristics of patients with methamphetamine-induced organic mental disorders that were seen in a psychiatric emergency service" Order ALL the reference details at left...
5.	Reserpine (Serpasil)FDA Link 01/01/1958 - "Comparative cross-sectional studies of serum protein conditions in exogenous traumatic psychoses & endogenous psychoses treated with reserpine, iminodibenzyl derivatives & phenothiazines.]" 01/01/1958 - "Comparative longitudinal section observation of serum protein ratios in exogenous traumatic psychoses and endogenous psychoses after treatment with reserpine, iminodibenzyl derivative and phenothiazines.]" Order ALL the reference details at left...
6.	PhenothiazinesIBA 01/01/1958 - "Comparative cross-sectional studies of serum protein conditions in exogenous traumatic psychoses & endogenous psychoses treated with reserpine, iminodibenzyl derivatives & phenothiazines.]" 01/01/1958 - "Comparative longitudinal section observation of serum protein ratios in exogenous traumatic psychoses and endogenous psychoses after treatment with reserpine, iminodibenzyl derivative and phenothiazines.]" Order ALL the reference details at left...
7.	Metrizamide FDA Link 09/01/1983 - "Organic mental disorder associated with metrizamide." 01/01/1986 - "A case of Capgras' Syndrome secondary to an Organic Mental Disorder associated with metrizamide myelography is presented" Order ALL the reference details at left...
8.	olanzapine (Zyprexa)FDA Link 02/01/2000 - "de Clerambault syndrome successfully treated with olanzapine." 04/01/2003 - "Higher olanzapine dosages were administered for patients with functional psychoses than for an analogous group with organic mental disorders" Order ALL the reference details at left...
9.	dibenzylamineIBA 01/01/1958 - "Comparative cross-sectional studies of serum protein conditions in exogenous traumatic psychoses & endogenous psychoses treated with reserpine, iminodibenzyl derivatives & phenothiazines.]" 01/01/1958 - "Comparative longitudinal section observation of serum protein ratios in exogenous traumatic psychoses and endogenous psychoses after treatment with reserpine, iminodibenzyl derivative and phenothiazines.]" Order ALL the reference details at left...
10.	Vitamin B 6IBA 01/01/2002 - "Moreover, there are anecdotal reports of a reduction in psychotic symptoms after vitamin B6 supplementation of psychopharmacologic treatment of patients suffering from schizophrenia or organic mental disorder" Order ALL the reference details at left...

Therapies and Procedures

1.	Palliative Care (Palliative Medicine) 03/01/2000 - "METHOD: A literature review was conducted, targeting primarily empirical studies that addressed the following topics: 1) psychological issues pertaining to life-threatening conditions; 2) family issues in the context of palliative care; 3) psychological issues and challenges faced by end-of-life health care providers; and 4) psychiatric disorders, including depression, anxiety, and organic mental disorders, in people with terminal illness" Order ALL the reference details at left...
2.	Neurosurgical Procedures 01/01/2008 - "In his recent novels one can find beautiful descriptions of patients with Huntington's disease, variant Creutzfeldt-Jakob disease, de Clerambault syndrome and also details about some neurosurgical procedures." Order ALL the reference details at left...
3.	Transplantation (Transplant Recipients) 01/01/1991 - "Cyclosporine-associated organic mental disorders in liver transplant recipients." Order ALL the reference details at left...
4.	Long-Term Care 01/01/1987 - "At follow up after one year, outcome in terms of mortality, admission to long-term care and dependency on others was worst for patients with organic mental disorder, even after matching for age and initial severity of physical impairment" Order ALL the reference details at left...
5.	Drug Therapy (Chemotherapy) 05/01/1999 - "These factors include: (1) diagnosis of generalized seizure disorder, (2) diagnosis of organic mental disorder, (3) concurrent pharmacotherapy with medications implicated in lowering the seizure threshold, and (4) abrupt change in pharmacotherapy" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Cognitive Disorders Amnestic Dementia Delirium

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>